Comparison

SSA antigenic peptide European Partner

Item no. HY-P4155-1ea
Manufacturer MedChem Express
Amount 1 ea
Category
Type Antigen
Specific against other
Purity 99.37
Formula C78H133N23O21S.0.15C2HF3O2
Citations [1]Xiao F, et al. Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome. Cell Mol Immunol. 2017 Jul 10;14(11):924–34.
Smiles [O=C(N[C@@H](C(C)C)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CCSC)C(N[C@@H](CC(O)=O)C(N[C@@H]([C@@H](C)CC)C(N2[C@@H](CCC2)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N.[O]C(C(F)(F)F)=O]
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352202
Shipping condition Cool pack
Available
Manufacturer - Type
Peptides
Manufacturer - Applications
COVID-19-immunoregulation
Manufacturer - Targets
Others
Shipping Temperature
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Product Description
SSA antigenic peptide is an antigenic peptide of Sjögren’s syndrome-related antigen A (SSA)[1].
Manufacturer - Research Area
Inflammation/Immunology
Solubility
H2O
Manufacturer - Pathway
Others
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close